{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:20:23Z","timestamp":1790864423992,"version":"4.1.0"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment for Alzheimer\u2019s disease (AD) can be more effective in the early stages. Although we do not completely understand the aetiology of the early stages of AD, potential pathological factors (amyloid beta [A\u03b2] and tau) and other co-factors have been identified as causes of AD, which may indicate some of the mechanism at work in the early stages of AD. Today, one of the primary techniques used to help delay or prevent AD in the early stages involves alleviating the unwanted effects of oxidative stress on A\u03b2 clearance. 4-Hydroxynonenal (HNE), a product of lipid peroxidation caused by oxidative stress, plays a key role in the adduction of the degrading proteases. This HNE employs a mechanism which decreases catalytic activity. This process ultimately impairs A\u03b2 clearance. The degradation of HNE-modified proteins helps to alleviate the unwanted effects of oxidative stress. Having a clear understanding of the mechanisms associated with the degradation of the HNE-modified proteins is essential for the development of strategies and for alleviating the unwanted effects of oxidative stress. The strategies which could be employed to decrease the effects of oxidative stress include enhancing antioxidant activity, as well as the use of nanozymes and\/or specific inhibitors. One area which shows promise in reducing oxidative stress is protein design. However, more research is needed to improve the effectiveness and accuracy of this technique. This paper discusses the interplay of potential pathological factors and AD. In particular, it focuses on the effect of oxidative stress on the expression of the A\u03b2-degrading proteases through adduction of the degrading proteases caused by HNE. The paper also elucidates other strategies that can be used to alleviate the unwanted effects of oxidative stress on A\u03b2 clearance. To improve the effectiveness and accuracy of protein design, we explain the application of quantum mechanical\/molecular mechanical approach.<\/jats:p>","DOI":"10.1186\/s40035-023-00344-2","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T02:02:38Z","timestamp":1678672958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Alleviating the unwanted effects of oxidative stress on A\u03b2 clearance: a review of related concepts and strategies for the development of computational modelling"],"prefix":"10.1186","volume":"12","author":[{"given":"Sarawoot","family":"Somin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-1578","authenticated-orcid":false,"given":"Don","family":"Kulasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Samarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"issue":"3","key":"344_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"A Association","year":"2019","unstructured":"Association A. 2019 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2019;15(3):321\u201387.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"344_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-016-0188-8","volume":"8","author":"M Prince","year":"2016","unstructured":"Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther. 2016;8(1):23.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"344_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"A Viswanathan","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871\u201380.","journal-title":"Ann Neurol"},{"issue":"7","key":"344_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.bbabio.2014.02.007","volume":"1837","author":"CM Pinho","year":"2014","unstructured":"Pinho CM, Teixeira PF, Glaser E. Mitochondrial import and degradation of amyloid-\u03b2 peptide. Biochim Biophys Acta. 2014;1837(7):1069\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"344_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1326-6-88","volume":"6","author":"TW Rajapaksha","year":"2011","unstructured":"Rajapaksha TW, Eimer WA, Bozza TC, Vassar R. The Alzheimer\u2019s \u03b2-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener. 2011;6:88.","journal-title":"Mol Neurodegener"},{"issue":"46","key":"344_CR6","doi-asserted-by":"publisher","first-page":"38408","DOI":"10.1074\/jbc.M112.415505","volume":"287","author":"B Hitt","year":"2012","unstructured":"Hitt B, Riordan SM, Kukreja L, Eimer WA, Rajapaksha TW, Vassar R. \u03b2-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. J Biol Chem. 2012;287(46):38408\u201325.","journal-title":"J Biol Chem"},{"issue":"5","key":"344_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/mp.2008.96","volume":"14","author":"KA Bates","year":"2009","unstructured":"Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, et al. Clearance mechanisms of Alzheimer\u2019s amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry. 2009;14(5):469\u201386.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"344_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04255-z","volume":"9","author":"Q Luo","year":"2018","unstructured":"Luo Q, Lin YX, Yang PP, Wang Y, Qi GB, Qiao ZY, et al. A self-destructive nanosweeper that captures and clears amyloid \u03b2-peptides. Nat Commun. 2018;9(1):1\u201312.","journal-title":"Nat Commun"},{"issue":"2","key":"344_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2217\/imt.11.170","volume":"4","author":"F Panza","year":"2012","unstructured":"Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, et al. Immunotherapy for Alzheimer\u2019s disease: from anti-\u03b2-amyloid to tau-based immunization strategies. Immunotherapy. 2012;4(2):213\u201338.","journal-title":"Immunotherapy"},{"issue":"1","key":"344_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, et al. Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017;8(1):1214.","journal-title":"Nat Commun"},{"issue":"3","key":"344_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148\u201360.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"344_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-010-0747-1","volume":"120","author":"G Giaccone","year":"2010","unstructured":"Giaccone G, Morbin M, Moda F, Botta M, Mazzoleni G, Uggetti A, et al. Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features. Acta Neuropathol. 2010;120(6):803\u201312.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"344_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"key":"344_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/497802","volume":"2014","author":"D Luque-Contreras","year":"2014","unstructured":"Luque-Contreras D, Carvajal K, Toral-Rios D, Franco-Bocanegra D, Campos-Pe\u00f1a V. Oxidative Stress and metabolic syndrome: cause or consequence of Alzheimer\u2019s disease? Oxid Med Cell Longev. 2014;2014: 497802.","journal-title":"Oxid Med Cell Longev"},{"key":"344_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 2018;14:450\u201364.","journal-title":"Redox Biol"},{"key":"344_CR16","doi-asserted-by":"publisher","first-page":"2930434","DOI":"10.1155\/2016\/2930434","volume":"2016","author":"B Antus","year":"2016","unstructured":"Antus B. Oxidative stress markers in sputum. Oxid Med Cell Longev. 2016;2016:2930434.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"344_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","volume":"52","author":"I Dalle-Donne","year":"2006","unstructured":"Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52(4):601\u201323.","journal-title":"Clin Chem"},{"key":"344_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2016.11.033","volume":"111","author":"W \u0141uczaj","year":"2017","unstructured":"\u0141uczaj W, G\u0119gotek A, Skrzydlewska E. Antioxidants and HNE in redox homeostasis. Free Radic Biol Med. 2017;111:87\u2013101.","journal-title":"Free Radic Biol Med"},{"issue":"4\u20135","key":"344_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/15216540051081092","volume":"50","author":"G Poli","year":"2000","unstructured":"Poli G, Schaur RJ. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life. 2000;50(4\u20135):315\u201321.","journal-title":"IUBMB Life"},{"key":"344_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2016.10.497","volume":"111","author":"JP Castro","year":"2017","unstructured":"Castro JP, Jung T, Grune T, Siems W. 4-Hydroxynonenal (HNE) modified proteins in metabolic diseases. Free Radic Biol Med. 2017;111:309\u201315.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"344_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/2211556009666191231155927","volume":"9","author":"S Kaur","year":"2020","unstructured":"Kaur S, Kumar P, Singh S. Oxidative stress targeting amyloid beta accumulation and clearance in Alzheimer\u2019s disease: insight into pathological mechanisms and therapeutic strategies. Curr Psychopharmacol. 2020;9(1):22\u201342.","journal-title":"Curr Psychopharmacol"},{"issue":"3","key":"344_CR22","first-page":"58406","volume":"2006","author":"DS Wang","year":"2006","unstructured":"Wang DS, Dickson DW, Malter JS. Beta-amyloid degradation and Alzheimer\u2019s disease. J Biomed Biotechnol. 2006;2006(3):58406.","journal-title":"J Biomed Biotechnol"},{"key":"344_CR23","first-page":"5457049","volume":"2020","author":"C Chen","year":"2020","unstructured":"Chen C, Qin H, Tan J, Hu Z, Zeng L. The role of ubiquitin-proteasome pathway and autophagy-lysosome pathway in cerebral ischemia. Oxid Med Cell Longev. 2020;2020:5457049.","journal-title":"Oxid Med Cell Longev"},{"key":"344_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/427318","volume":"2014","author":"T Persson","year":"2014","unstructured":"Persson T, Popescu BO, Cedazo-Minguez A. Oxidative stress in Alzheimer\u2019s disease: why did antioxidant therapy fail? Oxid Med Cell Longev. 2014;2014: 427318.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"344_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbadis.2011.10.003","volume":"1822","author":"CB Pocernich","year":"2012","unstructured":"Pocernich CB, Butterfield DA. Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta. 2012;1822(5):625\u201330.","journal-title":"Biochim Biophys Acta"},{"key":"344_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3389\/fchem.2020.00831","volume":"8","author":"R Tian","year":"2020","unstructured":"Tian R, Xu J, Luo Q, Hou C, Liu J. Rational design and biological application of antioxidant nanozymes. Front Chem. 2020;8:831.","journal-title":"Front Chem"},{"issue":"9","key":"344_CR27","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1021\/acs.jcim.8b00406","volume":"58","author":"R Lai","year":"2018","unstructured":"Lai R, Tang WJ, Li H. Catalytic mechanism of amyloid-\u03b2 peptide degradation by insulin degrading enzyme: insights from quantum mechanics and molecular mechanics style M\u00f8ller\u2013Plesset Second order perturbation theory calculation. J Chem Inf Model. 2018;58(9):1926\u201334.","journal-title":"J Chem Inf Model"},{"issue":"3","key":"344_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang H-Y, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14(3):168\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"344_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20(9):689\u2013709.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"344_CR30","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"344_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"344_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt258","volume":"6","author":"MP Kummer","year":"2014","unstructured":"Kummer MP, Heneka MT. Truncated and modified amyloid-beta species. Alzheimers Res Ther. 2014;6(3):28.","journal-title":"Alzheimers Res Ther"},{"issue":"41","key":"344_CR33","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, et al. Gamma-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009;29(41):13042\u201352.","journal-title":"J Neurosci"},{"issue":"3\u20134","key":"344_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/prca.201100082","volume":"6","author":"M Bibl","year":"2012","unstructured":"Bibl M, Gallus M, Welge V, Lehmann S, Sparbier K, Esselmann H, et al. Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-\u03b2 peptides. Proteomics Clin Appl. 2012;6(3\u20134):163\u20139.","journal-title":"Proteomics Clin Appl"},{"issue":"6","key":"344_CR35","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2009.06.002","volume":"32","author":"E Portelius","year":"2009","unstructured":"Portelius E, Price E, Brinkmalm G, Stiteler M, Olsson M, Persson R, et al. A novel pathway for amyloid precursor protein processing. Neurobiol Aging. 2009;32(6):1090\u20138.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"344_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2008.03.001","volume":"31","author":"U Konietzko","year":"2008","unstructured":"Konietzko U, Goodger ZV, Meyer M, Kohli BM, Bosset J, Lahiri DK, et al. Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol Aging. 2008;31(1):58\u201373.","journal-title":"Neurobiol Aging"},{"issue":"7232","key":"344_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/nature07767","volume":"457","author":"A Nikolaev","year":"2009","unstructured":"Nikolaev A, McLaughlin T, O\u2019Leary DDM, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature. 2009;457(7232):981\u20139.","journal-title":"Nature"},{"issue":"52","key":"344_CR38","doi-asserted-by":"publisher","first-page":"14459","DOI":"10.1523\/JNEUROSCI.4701-07.2007","volume":"27","author":"TL Young-Pearse","year":"2007","unstructured":"Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ. A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci. 2007;27(52):14459\u201369.","journal-title":"J Neurosci"},{"issue":"2","key":"344_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbrc.2011.06.133","volume":"411","author":"S Vivekanandan","year":"2011","unstructured":"Vivekanandan S, Brender JR, Lee SY, Ramamoorthy A. A partially folded structure of amyloid-beta(1\u201340) in an aqueous environment. Biochem Biophys Res Commun. 2011;411(2):312\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"344_CR40","doi-asserted-by":"publisher","first-page":"9081","DOI":"10.1074\/jbc.M111.292086","volume":"287","author":"L Gu","year":"2012","unstructured":"Gu L, Ngo S, Guo Z. Solid-support electron paramagnetic resonance (EPR) studies of A\u03b240 monomers reveal a structured state with three ordered segments. J Biol Chem. 2012;287(12):9081\u20139.","journal-title":"J Biol Chem"},{"issue":"7568","key":"344_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature15369","volume":"525","author":"Z Jaunmuktane","year":"2015","unstructured":"Jaunmuktane Z, Mead S, Ellis M, Wadsworth JDF, Nicoll AJ, Kenny J, et al. Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy. Nature. 2015;525(7568):247\u201350.","journal-title":"Nature"},{"key":"344_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2020.106421","volume":"264","author":"PH Nguyen","year":"2020","unstructured":"Nguyen PH, Derreumaux P. Structures of the intrinsically disordered A\u03b2, tau and \u03b1-synuclein proteins in aqueous solution from computer simulations. Biophys Chem. 2020;264: 106421.","journal-title":"Biophys Chem"},{"issue":"4","key":"344_CR43","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","volume":"121","author":"PH Nguyen","year":"2021","unstructured":"Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, et al. Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem Rev. 2021;121(4):2545\u2013647.","journal-title":"Chem Rev"},{"issue":"6","key":"344_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/alzrt226","volume":"5","author":"EY Hayden","year":"2013","unstructured":"Hayden EY, Teplow DB. Amyloid \u03b2-protein oligomers and Alzheimer\u2019s disease. Alzheimers Res Ther. 2013;5(6):60.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"344_CR45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"344_CR46","doi-asserted-by":"publisher","first-page":"106505","DOI":"10.1016\/j.bpc.2020.106505","volume":"268","author":"EE Cawood","year":"2021","unstructured":"Cawood EE, Karamanos TK, Wilson AJ, Radford SE. Visualizing and trapping transient oligomers in amyloid assembly pathways. Biophys Chem. 2021;268:106505.","journal-title":"Biophys Chem"},{"issue":"3","key":"344_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"T Tomiyama","year":"2008","unstructured":"Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. A new amyloid \u03b2 variant favoring oligomerization in Alzheimer\u2019s-type dementia. Ann Neurol. 2008;63(3):377\u201387.","journal-title":"Ann Neurol"},{"issue":"3","key":"344_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/13506129.2011.580399","volume":"18","author":"M Inayathullah","year":"2011","unstructured":"Inayathullah M, Teplow DB. Structural dynamics of the \u0394E22 (Osaka) familial Alzheimer\u2019s disease-linked amyloid \u03b2-protein. Amyloid. 2011;18(3):98\u2013107.","journal-title":"Amyloid"},{"issue":"5","key":"344_CR49","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1042\/BST0331087","volume":"33","author":"DM Walsh","year":"2005","unstructured":"Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, et al. The role of cell-derived oligomers of A\u03b2 in Alzheimer\u2019s disease and avenues for therapeutic intervention. Biochem Soc Trans. 2005;33(5):1087\u201390.","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"344_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14(8):837\u201342.","journal-title":"Nat Med"},{"issue":"23","key":"344_CR51","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1523\/JNEUROSCI.0482-13.2013","volume":"33","author":"CP Figueiredo","year":"2013","unstructured":"Figueiredo CP, Clarke JR, Ledo JH, Ribeiro FC, Costa CV, Melo HM, et al. Memantine rescues transient cognitive impairment caused by high-molecular-weight a\u03b2 oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J Neurosci. 2013;33(23):9626\u201334.","journal-title":"J Neurosci"},{"issue":"16","key":"344_CR52","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1523\/JNEUROSCI.5161-07.2008","volume":"28","author":"I Klyubin","year":"2008","unstructured":"Klyubin I, Betts V, Welzel AT, Blennow K, Zetterberg H, Wallin A, et al. Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J Neurosci. 2008;28(16):4231\u20137.","journal-title":"J Neurosci"},{"issue":"11","key":"344_CR53","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95(11):6448\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7082","key":"344_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesn\u00e9","year":"2006","unstructured":"Lesn\u00e9 S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440(7082):352\u20137.","journal-title":"Nature"},{"issue":"6880","key":"344_CR55","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416(6880):535\u20139.","journal-title":"Nature"},{"issue":"7","key":"344_CR56","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcp.24923","volume":"230","author":"G Zhu","year":"2015","unstructured":"Zhu G, Lee AS. Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J Cell Physiol. 2015;230(7):1413\u201320.","journal-title":"J Cell Physiol"},{"issue":"13","key":"344_CR57","doi-asserted-by":"publisher","first-page":"166993","DOI":"10.1016\/j.jmb.2021.166993","volume":"433","author":"BR Sahoo","year":"2021","unstructured":"Sahoo BR, Panda PK, Liang W, Tang WJ, Ahuja R, Ramamoorthy A. Degradation of Alzheimer\u2019s amyloid-\u03b2 by a catalytically inactive insulin-degrading enzyme. J Mol Biol. 2021;433(13):166993.","journal-title":"J Mol Biol"},{"key":"344_CR58","doi-asserted-by":"publisher","first-page":"106711","DOI":"10.1016\/j.bpc.2021.106711","volume":"281","author":"GJ Morgan","year":"2022","unstructured":"Morgan GJ. Transient disorder along pathways to amyloid. Biophys Chem. 2022;281:106711.","journal-title":"Biophys Chem"},{"issue":"4","key":"344_CR59","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bpj.2012.06.045","volume":"103","author":"MF Sciacca","year":"2012","unstructured":"Sciacca MF, Kotler SA, Brender JR, Chen J, Lee DK, Ramamoorthy A. Two-step mechanism of membrane disruption by A\u03b2 through membrane fragmentation and pore formation. Biophys J. 2012;103(4):702\u201310.","journal-title":"Biophys J"},{"issue":"3","key":"344_CR60","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","volume":"75","author":"CS Atwood","year":"2000","unstructured":"Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, et al. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem. 2000;75(3):1219\u201333.","journal-title":"J Neurochem"},{"issue":"1","key":"344_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","volume":"1502","author":"MA Smith","year":"2000","unstructured":"Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2000;1502(1):139\u201344.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"29","key":"344_CR62","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1021\/jp104073k","volume":"114","author":"H Jang","year":"2010","unstructured":"Jang H, Teran Arce F, Ramachandran S, Capone R, Lal R, Nussinov R. Structural convergence among diverse, toxic \u03b2-sheet ion channels. J Phys Chem B. 2010;114(29):9445\u201351.","journal-title":"J Phys Chem B"},{"issue":"5","key":"344_CR63","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jmb.2010.10.025","volume":"404","author":"H Jang","year":"2010","unstructured":"Jang H, Arce FT, Ramachandran S, Capone R, Lal R, Nussinov R. \u03b2-Barrel topology of Alzheimer\u2019s \u03b2-amyloid ion channels. J Mol Biol. 2010;404(5):917\u201334.","journal-title":"J Mol Biol"},{"issue":"32","key":"344_CR64","doi-asserted-by":"publisher","first-page":"16485","DOI":"10.1074\/jbc.R116.714576","volume":"291","author":"J Luo","year":"2016","unstructured":"Luo J, W\u00e4rml\u00e4nder SKTS, Gr\u00e4slund A, Abrahams JP. Cross-interactions between the Alzheimer disease amyloid-\u03b2 peptide and other amyloid proteins: a further aspect of the amyloid cascade hypothesis. J Biol Chem. 2016;291(32):16485\u201393.","journal-title":"J Biol Chem"},{"issue":"13","key":"344_CR65","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1074\/jbc.M112.400358","volume":"288","author":"JV Rushworth","year":"2013","unstructured":"Rushworth JV, Griffiths HH, Watt NT, Hooper NM. Prion protein-mediated toxicity of amyloid-\u03b2 oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem. 2013;288(13):8935\u201351.","journal-title":"J Biol Chem"},{"key":"344_CR66","doi-asserted-by":"publisher","first-page":"106507","DOI":"10.1016\/j.bpc.2020.106507","volume":"269","author":"MI Ivanova","year":"2021","unstructured":"Ivanova MI, Lin Y, Lee Y-H, Zheng J, Ramamoorthy A. Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology. Biophys Chem. 2021;269:106507.","journal-title":"Biophys Chem"},{"issue":"9","key":"344_CR67","doi-asserted-by":"publisher","first-page":"e1003537","DOI":"10.1371\/journal.ppat.1003537","volume":"9","author":"R Morales","year":"2013","unstructured":"Morales R, Moreno-Gonzalez I, Soto C. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog. 2013;9(9):e1003537.","journal-title":"PLoS Pathog"},{"issue":"5","key":"344_CR68","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/187152709789541998","volume":"8","author":"R Morales","year":"2009","unstructured":"Morales R, Green KM, Soto C. Cross currents in protein misfolding disorders: interactions and therapy. CNS Neurol Disord Drug Targets. 2009;8(5):363\u201371.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"344_CR69","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-122419","volume":"35","author":"C Xiao","year":"2013","unstructured":"Xiao C, Davis FJ, Chauhan BC, Viola KL, Lacor PN, Velasco PT, et al. Brain transit and ameliorative effects of intranasally delivered anti-amyloid-\u03b2 oligomer antibody in 5XFAD mice. J Alzheimers Dis. 2013;35(4):777\u201388.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"344_CR70","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41594-020-0505-6","volume":"27","author":"S Linse","year":"2020","unstructured":"Linse S, Scheidt T, Bernfur K, Vendruscolo M, Dobson CM, Cohen SIA, et al. Kinetic fingerprints differentiate the mechanisms of action of anti-A\u03b2 antibodies. Nat Struct Mol Biol. 2020;27(12):1125\u201333.","journal-title":"Nat Struct Mol Biol"},{"issue":"24","key":"344_CR71","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.1073\/pnas.1919464117","volume":"117","author":"FA Aprile","year":"2020","unstructured":"Aprile FA, Sormanni P, Podpolny M, Chhangur S, Needham LM, Ruggeri FS, et al. Rational design of a conformation-specific antibody for the quantification of A\u03b2 oligomers. Proc Natl Acad Sci U S A. 2020;117(24):13509\u201318.","journal-title":"Proc Natl Acad Sci"},{"issue":"24","key":"344_CR72","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1021\/acs.biochem.0c00328","volume":"59","author":"SJ Cox","year":"2020","unstructured":"Cox SJ, Lam B, Prasad A, Marietta HA, Stander NV, Joel JG, et al. High-throughput screening at the membrane interface reveals inhibitors of amyloid-\u03b2. Biochemistry. 2020;59(24):2249\u201358.","journal-title":"Biochemistry"},{"issue":"7618","key":"344_CR73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"51","key":"344_CR74","doi-asserted-by":"publisher","first-page":"21990","DOI":"10.1073\/pnas.1006091107","volume":"107","author":"JS Choi","year":"2010","unstructured":"Choi JS, Braymer JJ, Nanga RP, Ramamoorthy A, Lim MH. Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity. Proc Natl Acad Sci U S A. 2010;107(51):21990\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"344_CR75","doi-asserted-by":"publisher","first-page":"17842","DOI":"10.1038\/srep17842","volume":"5","author":"KJ Korshavn","year":"2015","unstructured":"Korshavn KJ, Jang M, Kwak YJ, Kochi A, Vertuani S, Bhunia A, et al. Reactivity of metal-free and metal-associated amyloid-\u03b2 with glycosylated polyphenols and their esterified derivatives. Sci Rep. 2015;5(1):17842.","journal-title":"Sci Rep"},{"issue":"4","key":"344_CR76","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","volume":"27","author":"SA Tatulian","year":"2022","unstructured":"Tatulian SA. Challenges and hopes for Alzheimer\u2019s disease. Drug Discov Today. 2022;27(4):1027\u201343.","journal-title":"Drug Discov Today"},{"issue":"34","key":"344_CR77","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1039\/D0CC01551B","volume":"56","author":"BR Sahoo","year":"2020","unstructured":"Sahoo BR, Cox SJ, Ramamoorthy A. High-resolution probing of early events in amyloid-\u03b2 aggregation related to Alzheimer\u2019s disease. Chem Comm. 2020;56(34):4627\u201339.","journal-title":"Chem Comm"},{"issue":"6","key":"344_CR78","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA. Proteolytic degradation of amyloid \u03b2-protein. Cold Spring Harb Perspect Med. 2012;2(6): a006379.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"344_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101283","volume":"26","author":"C de Dios","year":"2019","unstructured":"de Dios C, Bartolessis I, Roca-Agujetas V, Barbero-Camps E, Mari M, Morales A, et al. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress. Redox Biol. 2019;26: 101283.","journal-title":"Redox Biol"},{"issue":"6","key":"344_CR80","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s11064-019-02756-x","volume":"44","author":"NL Sikanyika","year":"2019","unstructured":"Sikanyika NL, Parkington HC, Smith AI, Kuruppu S. Powering amyloid beta degrading enzymes: a possible therapy for Alzheimer\u2019s disease. Neurochem Res. 2019;44(6):1289\u201396.","journal-title":"Neurochem Res"},{"issue":"6","key":"344_CR81","first-page":"247","volume":"10","author":"MJ Dhanavade","year":"2020","unstructured":"Dhanavade MJ, Sonawane KD. Amyloid beta peptide-degrading microbial enzymes and its implication in drug design. Biotech. 2020;10(6):247.","journal-title":"Biotech"},{"key":"344_CR82","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","volume":"8","author":"M Ries","year":"2016","unstructured":"Ries M, Sastre M. Mechanisms of A\u03b2 clearance and degradation by glial cells. Front Aging Neurosci. 2016;8:160.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"344_CR83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Zlokovic BV. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets. 2009;8(1):16\u201330.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"344_CR84","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s13273-021-00130-z","volume":"17","author":"J Bagaria","year":"2021","unstructured":"Bagaria J, Nho K, An SSA. Importance of GWAS in finding un-targeted genetic association of sporadic Alzheimer\u2019s disease. Mol Cell Toxicol. 2021;17(3):233\u201344.","journal-title":"Mol Cell Toxicol"},{"issue":"1","key":"344_CR85","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2010-1220","volume":"19","author":"WR Markesbery","year":"2010","unstructured":"Markesbery WR. Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis. 2010;19(1):221\u20138.","journal-title":"J Alzheimers Dis"},{"key":"344_CR86","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","volume":"111","author":"F Di Domenico","year":"2017","unstructured":"Di Domenico F, Tramutola A, Butterfield DA. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic Biol Med. 2017;111:253\u201361.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"344_CR87","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/jcp.54.3.176","volume":"54","author":"IS Young","year":"2001","unstructured":"Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol. 2001;54(3):176\u201386.","journal-title":"J Clin Pathol"},{"issue":"4","key":"344_CR88","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00019052-199708000-00004","volume":"10","author":"L Stefanis","year":"1997","unstructured":"Stefanis L, Burke RE, Greene LA. Apoptosis in neurodegenerative disorders. Curr Opin Neurol. 1997;10(4):299\u2013305.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"344_CR89","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1074\/jbc.R118.003214","volume":"294","author":"AK Hauck","year":"2019","unstructured":"Hauck AK, Huang Y, Hertzel AV, Bernlohr DA. Adipose oxidative stress and protein carbonylation. J Biol Chem. 2019;294(4):1083\u20138.","journal-title":"J Biol Chem"},{"key":"344_CR90","first-page":"2233906","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao T, Li J, Xia M, Li Y, Wang X, et al. Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases. J Immunol Res. 2022;2022:2233906.","journal-title":"J Immunol Res"},{"issue":"2","key":"344_CR91","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.pharmthera.2013.12.007","volume":"142","author":"J Navarro-Yepes","year":"2014","unstructured":"Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N, et al. Antioxidant gene therapy against neuronal cell death. Pharmacol Ther. 2014;142(2):206\u201330.","journal-title":"Pharmacol Ther"},{"key":"344_CR92","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"H Sies","year":"2015","unstructured":"Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180\u20133.","journal-title":"Redox Biol"},{"issue":"8","key":"344_CR93","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/00005072-199708000-00004","volume":"56","author":"KS Montine","year":"1997","unstructured":"Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol. 1997;56(8):866\u201371.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"344_CR94","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","volume":"18","author":"MA Lovell","year":"1997","unstructured":"Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer\u2019s disease. Neurobiol Aging. 1997;18(5):457\u201361.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"344_CR95","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.jprot.2011.05.004","volume":"74","author":"IM M\u00f8ller","year":"2011","unstructured":"M\u00f8ller IM, Rogowska-Wrzesinska A, Rao RSP. Protein carbonylation and metal-catalyzed protein oxidation in a cellular perspective. J Proteomics. 2011;74(11):2228\u201342.","journal-title":"J Proteomics"},{"key":"344_CR96","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2014.02.028","volume":"71","author":"A H\u00f6hn","year":"2014","unstructured":"H\u00f6hn A, Jung T, Grune T. Pathophysiological importance of aggregated damaged proteins. Free Radic Biol Med. 2014;71:70\u201389.","journal-title":"Free Radic Biol Med"},{"issue":"3\u20136","key":"344_CR97","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0921-8734(92)90036-O","volume":"275","author":"M Dizdaroglu","year":"1992","unstructured":"Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res. 1992;275(3\u20136):331\u201342.","journal-title":"Mutat Res"},{"issue":"10","key":"344_CR98","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","volume":"17","author":"MS Cooke","year":"2003","unstructured":"Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. Faseb J. 2003;17(10):1195\u2013214.","journal-title":"Faseb J"},{"issue":"1","key":"344_CR99","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41021-016-0051-y","volume":"39","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Kamiya H. Mutations induced by 8-hydroxyguanine (8-oxo-7,8-dihydroguanine), a representative oxidized base, in mammalian cells. Genes Environ. 2016;39(1):2.","journal-title":"Genes Environ"},{"issue":"10","key":"344_CR100","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111(10):5944\u201372.","journal-title":"Chem Rev"},{"key":"344_CR101","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014: 360438.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"344_CR102","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-7847.70902","volume":"4","author":"V Lobo","year":"2010","unstructured":"Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118\u201326.","journal-title":"Pharmacogn Rev"},{"issue":"3","key":"344_CR103","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-1110(90)90014-3","volume":"238","author":"H Esterbauer","year":"1990","unstructured":"Esterbauer H, Eckl P, Ortner A. Possible mutagens derived from lipids and lipid precursors. Mutat Res\/Rev in Genet Toxicol. 1990;238(3):223\u201333.","journal-title":"Mutat Res\/Rev in Genet Toxicol"},{"key":"344_CR104","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jmgm.2018.11.001","volume":"86","author":"A Alviz-Amador","year":"2019","unstructured":"Alviz-Amador A, Galindo-Murillo R, Pineda-Alem\u00e1n R, P\u00e9rez-Gonz\u00e1lez H, Rodr\u00edguez-Cavallo E, Vivas-Reyes R, et al. 4-HNE carbonylation induces local conformational changes on bovine serum albumin and thioredoxin. A molecular dynamics study. J Mol Graph Model. 2019;86:298\u2013307.","journal-title":"J Mol Graph Model"},{"issue":"1","key":"344_CR105","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","volume":"68","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem. 1997;68(1):255\u201364.","journal-title":"J Neurochem"},{"issue":"16","key":"344_CR106","doi-asserted-by":"publisher","first-page":"13389","DOI":"10.1074\/jbc.M111571200","volume":"277","author":"D Edbauer","year":"2002","unstructured":"Edbauer D, Willem M, Lammich S, Steiner H, Haass C. Insulin-degrading enzyme rapidly removes the \u03b2-amyloid precursor protein intracellular domain (AICD)*. J Biol Chem. 2002;277(16):13389\u201393.","journal-title":"J Biol Chem"},{"issue":"5","key":"344_CR107","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bbadis.2015.01.015","volume":"1852","author":"M Csala","year":"2015","unstructured":"Csala M, Kardon T, Legeza B, Liz\u00e1k B, Mandl J, Margittai \u00c9, et al. On the role of 4-hydroxynonenal in health and disease. Biochim Biophys Acta Mol Basis Dis. 2015;1852(5):826\u201338.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"344_CR108","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1021\/cr200085w","volume":"111","author":"EA Dennis","year":"2011","unstructured":"Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev. 2011;111(10):6130\u201385.","journal-title":"Chem Rev"},{"key":"344_CR109","doi-asserted-by":"publisher","first-page":"8848161","DOI":"10.1155\/2021\/8848161","volume":"2021","author":"AH Mariamenatu","year":"2021","unstructured":"Mariamenatu AH, Abdu EM. Overconsumption of omega-6 polyunsaturated fatty acids (PUFAs) versus deficiency of omega-3 PUFAs in modern-day diets: the disturbing factor for their balanced antagonistic metabolic functions in the human body. J Lipids. 2021;2021:8848161.","journal-title":"J Lipids"},{"issue":"1","key":"344_CR110","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jjcc.2015.08.002","volume":"67","author":"J Endo","year":"2016","unstructured":"Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardiol. 2016;67(1):22\u20137.","journal-title":"J Cardiol"},{"issue":"11","key":"344_CR111","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1194\/jlr.M094235","volume":"60","author":"I de Bus","year":"2019","unstructured":"de Bus I, Zuilhof H, Witkamp R, Balvers M, Albada B. Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages. J Lipid Res. 2019;60(11):1829\u201340.","journal-title":"J Lipid Res"},{"issue":"12","key":"344_CR112","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/bies.950171207","volume":"17","author":"HR Herschman","year":"1995","unstructured":"Herschman HR, Xie W, Reddy S. Inflammation, reproduction, cancer and all that? The regulation and role of the inducible prostaglandin synthase. BioEssays. 1995;17(12):1031\u20137.","journal-title":"BioEssays"},{"issue":"2","key":"344_CR113","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","volume":"47","author":"G Schmitz","year":"2008","unstructured":"Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47(2):147\u201355.","journal-title":"Prog Lipid Res"},{"issue":"10","key":"344_CR114","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3109\/10715762.2010.498477","volume":"44","author":"F Gu\u00e9raud","year":"2010","unstructured":"Gu\u00e9raud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, et al. Chemistry and biochemistry of lipid peroxidation products. Free Radic Res. 2010;44(10):1098\u2013124.","journal-title":"Free Radic Res"},{"issue":"4","key":"344_CR115","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/104454902753759672","volume":"21","author":"AD De Grey","year":"2002","unstructured":"De Grey AD. HO2*: the forgotten radical. DNA Cell Biol. 2002;21(4):251\u20137.","journal-title":"DNA Cell Biol"},{"issue":"6","key":"344_CR116","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","volume":"51","author":"S Mueller-Steiner","year":"2006","unstructured":"Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer\u2019s disease. Neuron. 2006;51(6):703\u201314.","journal-title":"Neuron"},{"issue":"49","key":"344_CR117","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem. 1998;273(49):32730\u20138.","journal-title":"J Biol Chem"},{"issue":"53","key":"344_CR118","doi-asserted-by":"publisher","first-page":"41443","DOI":"10.1074\/jbc.M110.141390","volume":"285","author":"ND Belyaev","year":"2010","unstructured":"Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, et al. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. J Biol Chem. 2010;285(53):41443\u201354.","journal-title":"J Biol Chem"},{"issue":"1","key":"344_CR119","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-0102(02)00015-9","volume":"43","author":"S Fukami","year":"2002","unstructured":"Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, et al. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res. 2002;43(1):39\u201356.","journal-title":"Neurosci Res"},{"issue":"1","key":"344_CR120","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-4-4","volume":"4","author":"J Zhao","year":"2009","unstructured":"Zhao J, Li L, Leissring MA. Insulin-degrading enzyme is exported via an unconventional protein secretion pathway. Mol Neurodegener. 2009;4(1):4.","journal-title":"Mol Neurodegener"},{"issue":"27","key":"344_CR121","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1016\/j.febslet.2005.09.054","volume":"579","author":"R Russo","year":"2005","unstructured":"Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A. Neprylisin decreases uniformly in Alzheimer\u2019s disease and in normal aging. FEBS Lett. 2005;579(27):6027\u201330.","journal-title":"FEBS Lett"},{"issue":"4","key":"344_CR122","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.bbrc.2012.07.014","volume":"424","author":"J Wang","year":"2012","unstructured":"Wang J, Ohno-Matsui K, Morita I. Cholesterol enhances amyloid \u03b2 deposition in mouse retina by modulating the activities of A\u03b2-regulating enzymes in retinal pigment epithelial cells. Biochem Biophys Res Commun. 2012;424(4):704\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"344_CR123","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","volume":"26","author":"A Caccamo","year":"2005","unstructured":"Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM. Age- and region-dependent alterations in A\u03b2-degrading enzymes: implications for A\u03b2-induced disorders. Neurobiol Aging. 2005;26(5):645\u201354.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"344_CR124","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s11064-007-9349-2","volume":"32","author":"L Fisk","year":"2007","unstructured":"Fisk L, Nalivaeva NN, Boyle JP, Peers CS, Turner AJ. Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res. 2007;32(10):1741\u20138.","journal-title":"Neurochem Res"},{"issue":"1","key":"344_CR125","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","volume":"310","author":"DS Wang","year":"2003","unstructured":"Wang DS, Iwata N, Hama E, Saido TC, Dickson DW. Oxidized neprilysin in aging and Alzheimer\u2019s disease brains. Biochem Biophys Res Commun. 2003;310(1):236\u201341.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"344_CR126","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1073\/pnas.0809620106","volume":"106","author":"VI P\u00e9rez","year":"2009","unstructured":"P\u00e9rez VI, Buffenstein R, Masamsetti V, Leonard S, Salmon AB, Mele J, et al. Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat. Proc Natl Acad Sci. 2009;106(9):3059\u201364.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"344_CR127","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-4159.2008.05855.x","volume":"108","author":"R Wang","year":"2009","unstructured":"Wang R, Wang S, Malter JS, Wang DS. Effects of HNE-modification induced by A\u03b2 on neprilysin expression and activity in SH-SY5Y cells. J Neurochem. 2009;108(4):1072\u201382.","journal-title":"J Neurochem"},{"issue":"9","key":"344_CR128","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1016\/S0021-9258(18)53264-6","volume":"268","author":"K Uchida","year":"1993","unstructured":"Uchida K, Stadtman ER. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J Biol Chem. 1993;268(9):6388\u201393.","journal-title":"J Biol Chem"},{"issue":"18","key":"344_CR129","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1073\/pnas.90.18.8742","volume":"90","author":"K Uchida","year":"1993","unstructured":"Uchida K, Szweda LI, Chae HZ, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A. 1993;90(18):8742\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"344_CR130","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/S0021-9258(18)53699-1","volume":"268","author":"LI Szweda","year":"1993","unstructured":"Szweda LI, Uchida K, Tsai L, Stadtman ER. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J Biol Chem. 1993;268(5):3342\u20137.","journal-title":"J Biol Chem"},{"issue":"49","key":"344_CR131","doi-asserted-by":"publisher","first-page":"34005","DOI":"10.1074\/jbc.M109.030627","volume":"284","author":"LA Ralat","year":"2009","unstructured":"Ralat LA, Ren M, Schilling AB, Tang WJ. Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation. J Biol Chem. 2009;284(49):34005\u201318.","journal-title":"J Biol Chem"},{"issue":"18","key":"344_CR132","doi-asserted-by":"publisher","first-page":"17701","DOI":"10.1074\/jbc.M501896200","volume":"280","author":"ES Song","year":"2005","unstructured":"Song ES, Daily A, Fried MG, Juliano MA, Juliano L, Hersh LB. Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions. J Biol Chem. 2005;280(18):17701\u20136.","journal-title":"J Biol Chem"},{"issue":"2","key":"344_CR133","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1073\/pnas.95.2.510","volume":"95","author":"DT Lucas","year":"1998","unstructured":"Lucas DT, Szweda LI. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci U S A. 1998;95(2):510\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"344_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038459","volume":"7","author":"RL Smathers","year":"2012","unstructured":"Smathers RL, Fritz KS, Galligan JJ, Shearn CT, Reigan P, Marks MJ, et al. Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS ONE. 2012;7(6): e38459.","journal-title":"PLoS ONE"},{"issue":"5","key":"344_CR135","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","volume":"84","author":"SA Farr","year":"2003","unstructured":"Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84(5):1173\u201383.","journal-title":"J Neurochem"},{"issue":"7","key":"344_CR136","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.freeradbiomed.2004.06.012","volume":"37","author":"DR Petersen","year":"2004","unstructured":"Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med. 2004;37(7):937\u201345.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"344_CR137","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1096\/fj.04-1743fje","volume":"18","author":"C Marques","year":"2004","unstructured":"Marques C, Pereira P, Taylor A, Liang JN, Reddy VN, Szweda LI, et al. Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells. FASEB J. 2004;18(12):1424\u20136.","journal-title":"Faseb J"},{"issue":"7","key":"344_CR138","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1096\/fasebj.11.7.9212076","volume":"11","author":"T Grune","year":"1997","unstructured":"Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. Faseb j. 1997;11(7):526\u201334.","journal-title":"Faseb j"},{"issue":"5","key":"344_CR139","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1091\/mbc.12.5.1293","volume":"12","author":"A Rocca","year":"2001","unstructured":"Rocca A, Lamaze C, Subtil A, Dautry-Varsat A. Involvement of the ubiquitin\/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol Biol Cell. 2001;12(5):1293\u2013301.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"344_CR140","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.freeradbiomed.2011.03.031","volume":"51","author":"F Shang","year":"2011","unstructured":"Shang F, Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med. 2011;51(1):5\u201316.","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"344_CR141","doi-asserted-by":"publisher","first-page":"9582","DOI":"10.1016\/S0021-9258(17)36921-1","volume":"269","author":"A Ciechanover","year":"1994","unstructured":"Ciechanover A, Shkedy D, Oren M, Bercovich B. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2. J Biol Chem. 1994;269(13):9582\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"344_CR142","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0092-8674(95)90021-7","volume":"82","author":"S Jentsch","year":"1995","unstructured":"Jentsch S, Schlenker S. Selective protein degradation: a journey\u2019s end within the proteasome. Cell. 1995;82(6):881\u20134.","journal-title":"Cell"},{"key":"344_CR143","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379.","journal-title":"Annu Rev Biochem"},{"key":"344_CR144","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1146\/annurev.bi.65.070196.004101","volume":"65","author":"O Coux","year":"1996","unstructured":"Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996;65:801\u201347.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"344_CR145","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2007.05.007","volume":"129","author":"GN Demartino","year":"2007","unstructured":"Demartino GN, Gillette TG. Proteasomes: machines for all reasons. Cell. 2007;129(4):659\u201362.","journal-title":"Cell"},{"issue":"3","key":"344_CR146","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nsmb.2958","volume":"22","author":"S Fishbain","year":"2015","unstructured":"Fishbain S, Inobe T, Israeli E, Chavali S, Yu H, Kago G, et al. Sequence composition of disordered regions fine-tunes protein half-life. Nat Struct Mol Biol. 2015;22(3):214\u201321.","journal-title":"Nat Struct Mol Biol"},{"issue":"19","key":"344_CR147","doi-asserted-by":"publisher","first-page":"11623","DOI":"10.1074\/jbc.270.19.11623","volume":"270","author":"I Jariel-Encontre","year":"1995","unstructured":"Jariel-Encontre I, Pari\u00e2t M, Carillo S, Salvai C, Piechaczyk M, Martini F. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26S proteasome. J Biol Chem. 1995;270(19):11623\u20137.","journal-title":"J Biol Chem"},{"issue":"5","key":"344_CR148","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1016\/S0021-9258(17)35950-1","volume":"261","author":"R Hough","year":"1986","unstructured":"Hough R, Pratt G, Rechsteiner M. Ubiquitin-lysozyme conjugates. Identification and characterization of an ATP-dependent protease from rabbit reticulocyte lysates. J Biol Chem. 1986;261(5):2400\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"344_CR149","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2010.12.020","volume":"41","author":"BM Stadtmueller","year":"2011","unstructured":"Stadtmueller BM, Hill CP. Proteasome activators. Mol Cell. 2011;41(1):8\u201319.","journal-title":"Mol Cell"},{"issue":"1","key":"344_CR150","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1074\/jbc.M206279200","volume":"278","author":"R Shringarpure","year":"2003","unstructured":"Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem. 2003;278(1):311\u20138.","journal-title":"J Biol Chem"},{"key":"344_CR151","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0014-5793(88)80306-5","volume":"236","author":"K Tanaka","year":"1988","unstructured":"Tanaka K, Ichihara A. Involvement of proteasomes (multicatalytic proteinase) in ATp dependent proteolysis in rat reticulocyte extracts. FEBS Lett. 1988;236:159.","journal-title":"FEBS Lett"},{"issue":"17","key":"344_CR152","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.1016\/S0021-9258(18)47564-3","volume":"262","author":"R Hough","year":"1987","unstructured":"Hough R, Pratt G, Rechsteiner M. Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J Biol Chem. 1987;262(17):8303\u201313.","journal-title":"J Biol Chem"},{"issue":"7","key":"344_CR153","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","volume":"93","author":"A Yoritaka","year":"1996","unstructured":"Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA. 1996;93(7):2696\u2013701.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"344_CR154","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","volume":"68","author":"LM Sayre","year":"1997","unstructured":"Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease. J Neurochem. 1997;68(5):2092\u20137.","journal-title":"J Neurochem"},{"issue":"8","key":"344_CR155","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cardfail.2009.04.008","volume":"15","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Miura D, Kusano KF, Fujimoto Y, Sumita-Yoshikawa W, Fuke S, et al. 4-Hydroxy-2-nonenal induces calcium overload via the generation of reactive oxygen species in isolated rat cardiac myocytes. J Card Fail. 2009;15(8):709\u201316.","journal-title":"J Card Fail"},{"issue":"4","key":"344_CR156","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728\u201341.","journal-title":"Cell"},{"issue":"3","key":"344_CR157","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tem.2009.10.003","volume":"21","author":"AM Cuervo","year":"2010","unstructured":"Cuervo AM. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab. 2010;21(3):142\u201350.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"344_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1474-9726.2011.00752.x","volume":"11","author":"T Uchiki","year":"2012","unstructured":"Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak D, et al. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell. 2012;11(1):1\u201313.","journal-title":"Aging Cell"},{"key":"344_CR159","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","volume":"78","author":"D Finley","year":"2009","unstructured":"Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem. 2009;78:477\u2013513.","journal-title":"Annu Rev Biochem"},{"key":"344_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00128","author":"NM Kocaturk","year":"2018","unstructured":"Kocaturk NM, Gozuacik D. Crosstalk between mammalian autophagy and the ubiquitin-proteasome system. Front Cell Dev Biol. 2018. https:\/\/doi.org\/10.3389\/fcell.2018.00128.","journal-title":"Front Cell Dev Biol"},{"issue":"32","key":"344_CR161","doi-asserted-by":"publisher","first-page":"E4639","DOI":"10.1073\/pnas.1608644113","volume":"113","author":"O Braten","year":"2016","unstructured":"Braten O, Livneh I, Ziv T, Admon A, Kehat I, Caspi LH, et al. Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination. Proc Natl Acad Sci U S A. 2016;113(32):E4639\u201347.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"344_CR162","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1747-1028-5-19","volume":"5","author":"M Sadowski","year":"2010","unstructured":"Sadowski M, Sarcevic B. Mechanisms of mono- and poly-ubiquitination: ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine. Cell Div. 2010;5:19.","journal-title":"Cell Div"},{"issue":"11","key":"344_CR163","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","volume":"29","author":"BP Tseng","year":"2008","unstructured":"Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging. 2008;29(11):1607\u201318.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"344_CR164","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1074\/jbc.272.1.58","volume":"272","author":"L Gregori","year":"1997","unstructured":"Gregori L, Hainfeld JF, Simon MN, Goldgaber D. Binding of amyloid beta protein to the 20S proteasome. J Biol Chem. 1997;272(1):58\u201362.","journal-title":"J Biol Chem"},{"issue":"1","key":"344_CR165","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41467-018-03509-0","volume":"9","author":"TA Thibaudeau","year":"2018","unstructured":"Thibaudeau TA, Anderson RT, Smith DM. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat Commun. 2018;9(1):1097.","journal-title":"Nat Commun"},{"issue":"1","key":"344_CR166","doi-asserted-by":"publisher","first-page":"10963","DOI":"10.1038\/ncomms10963","volume":"7","author":"WH Choi","year":"2016","unstructured":"Choi WH, de Poot SAH, Lee JH, Kim JH, Han DH, Kim YK, et al. Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun. 2016;7(1):10963.","journal-title":"Nat Commun"},{"issue":"33","key":"344_CR167","doi-asserted-by":"publisher","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","volume":"272","author":"BS Berlett","year":"1997","unstructured":"Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem. 1997;272(33):20313\u20136.","journal-title":"J Biol Chem"},{"issue":"3","key":"344_CR168","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1073\/pnas.80.3.707","volume":"80","author":"ME Anderson","year":"1983","unstructured":"Anderson ME, Meister A. Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis. Proc Natl Acad Sci U S A. 1983;80(3):707\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"344_CR169","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/antiox9070600","volume":"9","author":"L Mursaleen","year":"2020","unstructured":"Mursaleen L, Noble B, Chan SHY, Somavarapu S, Zariwala MG. N-acetylcysteine nanocarriers protect against oxidative stress in a cellular model of Parkinson\u2019s disease. Antioxidants (Basel). 2020;9(7):600.","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"344_CR170","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/jnr.10810","volume":"74","author":"J Drake","year":"2003","unstructured":"Drake J, Sultana R, Aksenova M, Calabrese V, Butterfield DA. Elevation of mitochondrial glutathione by \u03b3-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J Neurosci Res. 2003;74(6):917\u201327.","journal-title":"J Neurosci Res"},{"issue":"4","key":"344_CR171","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12017-008-8037-y","volume":"10","author":"TG Son","year":"2008","unstructured":"Son TG, Camandola S, Mattson MP. Hormetic dietary phytochemicals. Neuromol Med. 2008;10(4):236\u201346.","journal-title":"Neuromol Med"},{"issue":"8","key":"344_CR172","first-page":"3486","volume":"61","author":"CM Bradbury","year":"2001","unstructured":"Bradbury CM, Locke JE, Wei SJ, Rene LM, Karimpour S, Hunt C, et al. Increased activator protein 1 activity as well as resistance to heat-induced radiosensitization, hydrogen peroxide, and cisplatin are inhibited by indomethacin in oxidative stress-resistant cells. Cancer Res. 2001;61(8):3486\u201392.","journal-title":"Cancer Res"},{"issue":"4","key":"344_CR173","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3727\/000000002783992442","volume":"10","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Spitz DR, Gandhi P, Lin HY, Crawford DR. Mammalian resistance to oxidative stress: a comparative analysis. Gene Expr. 2002;10(4):179\u201391.","journal-title":"Gene Expr"},{"issue":"5","key":"344_CR174","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0891-5849(95)02151-5","volume":"20","author":"KZ Guyton","year":"1996","unstructured":"Guyton KZ, Spitz DR, Holbrook NJ. Expression of stress response genes GADD153, c-jun, and heme oxygenase-1 in H2O2- and O2-resistant fibroblasts. Free Radic Biol Med. 1996;20(5):735\u201341.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"344_CR175","doi-asserted-by":"publisher","first-page":"e51179","DOI":"10.1371\/journal.pone.0051179","volume":"7","author":"S Basak","year":"2012","unstructured":"Basak S, Jiang R. Enhancing E. coli tolerance towards oxidative stress via engineering its global regulator cAMP receptor protein (CRP). PLoS One. 2012;7(12):e51179.","journal-title":"PLoS ONE"},{"issue":"4","key":"344_CR176","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1039\/C8CS00457A","volume":"48","author":"J Wu","year":"2019","unstructured":"Wu J, Wang X, Wang Q, Lou Z, Li S, Zhu Y, et al. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II). Chem Soc Rev. 2019;48(4):1004\u201376.","journal-title":"Chem Soc Rev"},{"key":"344_CR177","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcis.2015.07.034","volume":"457","author":"MJ Akhtar","year":"2015","unstructured":"Akhtar MJ, Ahamed M, Alhadlaq HA, Alshamsan A, Majeed Khan MA, Alrokayan SA. Antioxidative and cytoprotective response elicited by molybdenum nanoparticles in human cells. J Colloid Interface Sci. 2015;457:370\u20137.","journal-title":"J Colloid Interface Sci"},{"key":"344_CR178","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.redox.2016.12.011","volume":"11","author":"J Morry","year":"2017","unstructured":"Morry J, Ngamcherdtrakul W, Yantasee W. Oxidative stress in cancer and fibrosis: opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol. 2017;11:240\u201353.","journal-title":"Redox Biol"},{"issue":"3","key":"344_CR179","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0891-5849(94)90079-5","volume":"17","author":"C Michiels","year":"1994","unstructured":"Michiels C, Raes M, Toussaint O, Remacle J. Importance of SE-glutathione peroxidase, catalase, and CU\/ZN-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994;17(3):235\u201348.","journal-title":"Free Radic Biol Med"},{"issue":"7_Supplement","key":"344_CR180","first-page":"1969s","volume":"54","author":"A Meister","year":"1994","unstructured":"Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994;54(7_Supplement):1969s-s1975.","journal-title":"Cancer Res"},{"issue":"3","key":"344_CR181","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/sj.embor.7400645","volume":"7","author":"S Chakravarthi","year":"2006","unstructured":"Chakravarthi S, Jessop CE, Bulleid NJ. The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO Rep. 2006;7(3):271\u20135.","journal-title":"EMBO Rep"},{"issue":"930","key":"344_CR182","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/pmj.79.930.195","volume":"79","author":"ZS Nedeljkovic","year":"2003","unstructured":"Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J. 2003;79(930):195\u20139.","journal-title":"Postgrad Med J"},{"issue":"43","key":"344_CR183","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1002\/adfm.201602932","volume":"26","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Zhang Y, Guan Y, Liu Z, Ren J, et al. Artificial metalloenzyme-based enzyme replacement therapy for the treatment of hyperuricemia. Adv Funct Mater. 2016;26(43):7921\u20138.","journal-title":"Adv Funct Mater"},{"issue":"38","key":"344_CR184","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1002\/anie.201704904","volume":"56","author":"M Soh","year":"2017","unstructured":"Soh M, Kang DW, Jeong HG, Kim D, Kim DY, Yang W, et al. Ceria-zirconia nanoparticles as an enhanced multi-antioxidant for sepsis treatment. Angew Chem Int Ed Engl. 2017;56(38):11399\u2013403.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"15","key":"344_CR185","doi-asserted-by":"publisher","first-page":"12453","DOI":"10.1021\/acsami.8b01245","volume":"10","author":"T Chen","year":"2018","unstructured":"Chen T, Zou H, Wu X, Liu C, Situ B, Zheng L, et al. Nanozymatic antioxidant system based on MoS2 nanosheets. ACS Appl Mater Interfaces. 2018;10(15):12453\u201362.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"31","key":"344_CR186","doi-asserted-by":"publisher","first-page":"26108","DOI":"10.1021\/acsami.8b10345","volume":"10","author":"J Zhao","year":"2018","unstructured":"Zhao J, Cai X, Gao W, Zhang L, Zou D, Zheng Y, et al. Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl Mater Interfaces. 2018;10(31):26108\u201317.","journal-title":"ACS Appl Mater Interfaces"},{"key":"344_CR187","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1073\/pnas.0608582104","volume":"104","author":"T Cedervall","year":"2007","unstructured":"Cedervall T, Lynch I, Lindman S, Bergg\u00e5rd T, Thulin E, Nilsson H, et al. From the cover: understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 2007;104:2050\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"47","key":"344_CR188","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0807296105","volume":"105","author":"B Wang","year":"2008","unstructured":"Wang B, Zhang L, Bae SC, Granick S. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci U S A. 2008;105(47):18171\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"344_CR189","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","volume":"1842","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA, Di Domenico F, Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta. 2014;1842(9):1693\u2013706.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"344_CR190","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110708","volume":"9","author":"HM Ismail","year":"2014","unstructured":"Ismail HM, Scapozza L, Ruegg UT, Dorchies OM. Diapocynin, a dimer of the NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic muscle. PLoS One. 2014;9(10):e110708.","journal-title":"PLoS ONE"},{"key":"344_CR191","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","volume":"107","author":"E Croteau","year":"2018","unstructured":"Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, et al. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease. Exp Gerontol. 2018;107:18\u201326.","journal-title":"Exp Gerontol"},{"issue":"4","key":"344_CR192","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2337\/dc17-2132","volume":"41","author":"A Digenio","year":"2018","unstructured":"Digenio A, Pham NC, Watts LM, Morgan ES, Jung SW, Baker BF, et al. Antisense inhibition of protein tyrosine phosphatase 1B with IONIS-PTP-1B(Rx) improves insulin sensitivity and reduces weight in overweight patients with type 2 diabetes. Diabetes Care. 2018;41(4):807\u201314.","journal-title":"Diabetes Care"},{"issue":"9","key":"344_CR193","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/13543784.2019.1654993","volume":"28","author":"A Egan","year":"2019","unstructured":"Egan A, Vella A. TTP399: an investigational liver-selective glucokinase (GK) activator as a potential treatment for type 2 diabetes. Expert Opin Investig Drugs. 2019;28(9):741\u20137.","journal-title":"Expert Opin Investig Drugs"},{"key":"344_CR194","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ejmech.2017.09.029","volume":"141","author":"R Kaur","year":"2017","unstructured":"Kaur R, Dahiya L, Kumar M. Fructose-1,6-bisphosphatase inhibitors: a new valid approach for management of type 2 diabetes mellitus. Eur J Med Chem. 2017;141:473\u2013505.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"344_CR195","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-0028-1128142","volume":"41","author":"B Liter\u00e1ti-Nagy","year":"2009","unstructured":"Liter\u00e1ti-Nagy B, Kulcs\u00e1r E, Liter\u00e1ti-Nagy Z, Buday B, P\u00e9terfai E, Horv\u00e1th T, et al. Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. Horm Metab Res. 2009;41(5):374\u201380.","journal-title":"Horm Metab Res"},{"issue":"2","key":"344_CR196","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/met.2013.0098","volume":"12","author":"B Liter\u00e1ti-Nagy","year":"2014","unstructured":"Liter\u00e1ti-Nagy B, Tory K, Peitl B, Bajza \u00c1, Kor\u00e1nyi L, Liter\u00e1ti-Nagy Z, et al. Improvement of insulin sensitivity by a novel drug candidate, BGP-15, in different animal studies. Metab Syndr Relat Disord. 2014;12(2):125\u201331.","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"344_CR197","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.biotechadv.2018.10.011","volume":"37","author":"Q Liu","year":"2019","unstructured":"Liu Q, Xun G, Feng Y. The state-of-the-art strategies of protein engineering for enzyme stabilization. Biotechnol Adv. 2019;37(4):530\u20137.","journal-title":"Biotechnol Adv"},{"issue":"12","key":"344_CR198","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.90.12.5618","volume":"90","author":"K Chen","year":"1993","unstructured":"Chen K, Arnold FH. Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide. Proc Natl Acad Sci U S A. 1993;90(12):5618\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"344_CR199","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cbpa.2009.01.017","volume":"13","author":"CA Tracewell","year":"2009","unstructured":"Tracewell CA, Arnold FH. Directed enzyme evolution: climbing fitness peaks one amino acid at a time. Curr Opin Chem Biol. 2009;13(1):3\u20139.","journal-title":"Curr Opin Chem Biol"},{"key":"344_CR200","first-page":"309","volume":"37","author":"SS Khawar","year":"2016","unstructured":"Khawar SS. Defying the activity\u2013stability trade-off in enzymes: taking advantage of entropy to enhance activity and thermostability. Crit Rev Biotechnol. 2016;37:309.","journal-title":"Crit Rev Biotechnol"},{"issue":"2","key":"344_CR201","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1367-5931(00)00182-4","volume":"5","author":"UT Bornscheuer","year":"2001","unstructured":"Bornscheuer UT, Pohl M. Improved biocatalysts by directed evolution and rational protein design. Curr Opin Chem Biol. 2001;5(2):137\u201343.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"344_CR202","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbapap.2010.06.021","volume":"1814","author":"AA Gilep","year":"2011","unstructured":"Gilep AA, Sushko TA, Usanov SA. At the crossroads of steroid hormone biosynthesis: the role, substrate specificity and evolutionary development of CYP17. Biochim Biophys Acta. 2011;1814(1):200\u20139.","journal-title":"Biochim Biophys Acta - Proteins Proteom"},{"issue":"1","key":"344_CR203","doi-asserted-by":"publisher","first-page":"16375","DOI":"10.1038\/s41598-017-16768-6","volume":"7","author":"H-M Qin","year":"2017","unstructured":"Qin H-M, Zhu Z, Ma Z, Xu P, Guo Q, Li S, et al. Rational design of cholesterol oxidase for efficient bioresolution of cholestane skeleton substrates. Sci Rep. 2017;7(1):16375.","journal-title":"Sci Rep"},{"issue":"4","key":"344_CR204","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.copbio.2005.06.004","volume":"16","author":"RA Chica","year":"2005","unstructured":"Chica RA, Doucet N, Pelletier JN. Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design. Curr Opin Biotechnol. 2005;16(4):378\u201384.","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"344_CR205","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tibtech.2005.03.005","volume":"23","author":"KL Morley","year":"2005","unstructured":"Morley KL, Kazlauskas RJ. Improving enzyme properties: when are closer mutations better? Trends Biotechnol. 2005;23(5):231\u20137.","journal-title":"Trends Biotechnol"},{"issue":"7","key":"344_CR206","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1073\/pnas.022039799","volume":"99","author":"SW Santoro","year":"2002","unstructured":"Santoro SW, Schultz PG. Directed evolution of the site specificity of Cre recombinase. Proc Natl Acad Sci U S A. 2002;99(7):4185\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"344_CR207","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41580-019-0163-x","volume":"20","author":"B Kuhlman","year":"2019","unstructured":"Kuhlman B, Bradley P. Advances in protein structure prediction and design. Nat Rev Mol Cell Biol. 2019;20(11):681\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7423","key":"344_CR208","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11600","volume":"491","author":"N Koga","year":"2012","unstructured":"Koga N, Tatsumi-Koga R, Liu G, Xiao R, Acton TB, Montelione GT, et al. Principles for designing ideal protein structures. Nature. 2012;491(7423):222\u20137.","journal-title":"Nature"},{"issue":"6468","key":"344_CR209","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.aax8780","volume":"366","author":"AA Glasgow","year":"2019","unstructured":"Glasgow AA, Huang YM, Mandell DJ, Thompson M, Ritterson R, Loshbaugh AL, et al. Computational design of a modular protein sense-response system. Science. 2019;366(6468):1024\u20138.","journal-title":"Science"},{"issue":"1","key":"344_CR210","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"344_CR211","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1038\/s41598-018-25471-z","volume":"8","author":"X Wang","year":"2018","unstructured":"Wang X, Li R, Cui W, Li Q, Yao J. QM\/MM free energy simulations of an efficient gluten hydrolase (Kuma030) implicate for a reactant-state based protein-design strategy for general acid\/base catalysis. Sci Rep. 2018;8(1):7042.","journal-title":"Sci Rep"},{"key":"344_CR212","doi-asserted-by":"crossref","unstructured":"Akcapinar GB, Sezerman OU.  Computational approaches for de novo design and redesign of metal-binding sites on proteins. Biosci Rep. 2017; 37(2):BSR20160179.","DOI":"10.1042\/BSR20160179"},{"issue":"7620","key":"344_CR213","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature19946","volume":"537","author":"P-S Huang","year":"2016","unstructured":"Huang P-S, Boyken SE, Baker D. The coming of age of de novo protein design. Nature. 2016;537(7620):320\u20137.","journal-title":"Nature"},{"issue":"8","key":"344_CR214","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1021\/cr050293k","volume":"106","author":"J Gao","year":"2006","unstructured":"Gao J, Ma S, Major DT, Nam K, Pu J, Truhlar DG. Mechanisms and free energies of enzymatic reactions. Chem Rev. 2006;106(8):3188\u2013209.","journal-title":"Chem Rev"},{"issue":"7","key":"344_CR215","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/anie.200802019","volume":"48","author":"HM Senn","year":"2009","unstructured":"Senn HM, Thiel W. QM\/MM methods for biomolecular systems. Angew Chem. 2009;48(7):1198\u2013229.","journal-title":"Angew Chem"},{"issue":"19","key":"344_CR216","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1073\/pnas.0408036102","volume":"102","author":"RA Friesner","year":"2005","unstructured":"Friesner RA. Ab initio quantum chemistry: methodology and applications. Proc Natl Acad Sci U S A. 2005;102(19):6648\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"344_CR217","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1039\/C8RE00213D","volume":"4","author":"Z Yang","year":"2018","unstructured":"Yang Z, Mehmood R, Wang M, Qi H, Steeves A, Kulik H. Revealing quantum mechanical effects in enzyme catalysis with large-scale electronic structure simulation. React Chem Eng. 2018;4:298.","journal-title":"React Chem Eng"},{"issue":"20","key":"344_CR218","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.1021\/jacs.7b02671","volume":"139","author":"F Himo","year":"2017","unstructured":"Himo F. Recent trends in quantum chemical modeling of enzymatic reactions. J Am Chem Soc. 2017;139(20):6780\u20136.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"344_CR219","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/ci500544c","volume":"55","author":"CHB da Cruz","year":"2015","unstructured":"da Cruz CHB, Seabra GM. QM\/MM simulations of amyloid-\u03b2 42 degradation by IDE in the presence and absence of ATP. J Chem Inf Model. 2015;55(1):72\u201383.","journal-title":"J Chem Inf Model"},{"issue":"12","key":"344_CR220","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.3390\/ijms21124477","volume":"21","author":"YR Huang","year":"2020","unstructured":"Huang YR, Liu RT. The toxicity and polymorphism of \u03b2-amyloid oligomers. Int J Mol Sci. 2020;21(12):4477.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"344_CR221","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3233\/JAD-171145","volume":"62","author":"RN Martins","year":"2018","unstructured":"Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, et al. Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies. J Alzheimers Dis. 2018;62(3):965\u201392.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"344_CR222","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/cdd.2013.138","volume":"20","author":"S Dalleau","year":"2013","unstructured":"Dalleau S, Baradat M, Gu\u00e9raud F, Huc L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013;20(12):1615\u201330.","journal-title":"Cell Death Differ"},{"issue":"8","key":"344_CR223","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0028-3908(01)00019-3","volume":"40","author":"Y Gilgun-Sherki","year":"2001","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 2001;40(8):959\u201375.","journal-title":"Neuropharmacology"},{"issue":"5","key":"344_CR224","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bj.2017.06.007","volume":"40","author":"S Hurrle","year":"2017","unstructured":"Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. 2017;40(5):257\u201362.","journal-title":"Biomed J"},{"issue":"1","key":"344_CR225","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"AP Rolo","year":"2012","unstructured":"Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012;52(1):59\u201369.","journal-title":"Free Radic Biol Med"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00344-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00344-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T03:05:56Z","timestamp":1678676756000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00344-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":225,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00344-2","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}